Showing results (71-80 of 547) with videos related to
Sort By:
Pageof 55
European Urology|December 19, 2025
Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant GroupAndrew J Vickers, Samson Fine, British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.European Urology|October 29, 2024
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended DissectionKarim A Touijer, Emily A Vertosick, Daniel D Sjoberg, et al.European Urology Oncology|August 15, 2019
Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative MorbidityAntoni Vilaseca, Giuliano Guglielmetti, Emily A Vertosick, et al.Journal of the National Cancer Institute|April 12, 2015
Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT studyRichard J Bryant, Daniel D Sjoberg, Andrew J Vickers, et al.Urologic Oncology|January 11, 2023
Association of smoking history on health-related quality of life in patients undergoing radical cystecomyBenjamin B Beech, Alexander D Doudt, Daniel D Sjoberg, et al.BJU International|December 11, 2020
Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohortPeter E Lonergan, Emily A Vertosick, Melissa Assel, et al.Health and Quality of Life Outcomes|April 28, 2017
Manifesto: towards a clinically-oriented psychometricsAndrew J Vickers, Ling Y ChenUrologic Oncology|July 31, 2004
Incorporating predictions of individual patient risk in clinical trialsMichael W Kattan, Andrew J VickersSeminars in Oncology|February 23, 2010
Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic frameworkAndrew J Vickers, Angel M CroninPageof 55